Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Brazil Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20061
20083
20091
20111
20121
20131
20151
20162
20174
20181
20193
20202
20216
20222
20234
20242
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated11
Recruiting8
Active, not recruiting3
Unknown status3
Not yet recruiting2
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo General Hospital9
Actelion6
United Therapeutics5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Bayer3
Biogen2
Insmed Incorporated2
University of Nove de Julho2
Aerovate Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension48
Hypertension, Pulmonary16
Cardiovascular Diseases4
Hypertension3
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Schistosomiasis2
Vascular Diseases2

Trials

Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.